Morepen Laboratories (MOREPENLAB.NS) Stock Price

Morepen Laboratories Price

NSE·CLOSED
127.83
​
Market closed

Over the last 19 years Morepen Laboratories grew revenue by 14.9% annually, reaching 18.12 B INR. Earnings per share have grown at 49.3% per year over the last 10 years. For Morepen Laboratories, the net margin of 6.5% is down versus 8.2% a few years ago. At today's price the dividend yield works out to roughly 0.16%. The payout ratio is around 9% of earnings.

Morepen Laboratories stock price

Access this data via the Eulerpool API

Morepen Laboratories business model & stock analysis

Morepen Laboratories Ltd. engages in the manufacture and market of bulk drugs and pharmaceutical formulations. The company is headquartered in Gurgaon, Haryana and currently employs 1,649 full-time employees. The firm is engaged in the business of manufacturing, producing, developing, and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also the home health products. Its APIs include Apixaban, Edoxaban, Sitagliptin, Linagliptin, Empagliflozin, Atorvastatin, Loratadine, Desloratadine, Montelukast Sodium, Atorvastatin Calcium, Fexofenadine, Sitagliptin Phosphate, Vildagliptin and Rivaroxaban, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.

Frequently asked questions about Morepen Laboratories

7 analysts currently rate the Morepen Laboratories stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Morepen Laboratories share trades at 1.20 EUR (127.83 INR).

The Morepen Laboratories share (MOREPENLAB.NS) is listed on 2 stock exchanges, including: NSE (Indien) (MOREPENLAB.NS).

The revenue cannot currently be calculated for Morepen Laboratories.

The profit cannot currently be calculated for Morepen Laboratories.

The P/E ratio cannot be calculated for Morepen Laboratories at the moment.

The P/S cannot be calculated for Morepen Laboratories currently.

The Eulerpool Quality Score for Morepen Laboratories is 6/10.

The ISIN of Morepen Laboratories is INE083A01026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Morepen Laboratories is MOREPENLAB.NS. The ticker symbol is used to trade Morepen Laboratories shares on the stock exchange.

Fair ValueTerminal
132.94 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
10.99 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website morepen.com
Country
Currency
INR
Initial public offering
Nov 16, 1992
ISIN
INE083A01026
Cusip
Y6138R139
Market capitalization
68.42 B INRLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
47.56
P/B Ratio
5.92
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.51 %
Last updated Oct 13, 2026, 2:07 PM

Morepen Laboratories Peer Group

Morepen Laboratories Ticker

BSE · MOREPENLAB.BONSE INDIA · MOREPENLAB.NS

Morepen Laboratories FIGI

MORE:IN · BBG000CWMBB4MORE:IB · BBG000CWMBK4MORE:IS · BBG000CWMCC1MORE:IG · BBG003NVX7Z9